Clinical Trials Directory

Trials / Completed

CompletedNCT04712500

A Food-Effect Study of AND017 in Healthy Participants

A Single-Center, Randomized, Open-Label, Two-Sequence, Two-Period Crossover Study in Healthy Non-Elderly Chinese Subjects to Evaluate the Food Effect on the Pharmacokinetics of AND017 Following Oral Single-Dose Administration

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
14 (actual)
Sponsor
Kind Pharmaceuticals LLC · Industry
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

The purpose of this phase I study is to evaluate the food effect on the PKs of AND017 following oral single-dose administration in healthy non-elderly Chinese subjects.

Detailed description

This is a single-center, randomized, open-label, two-sequence, two-period crossover study in healthy non-elderly Chinese subjects to evaluate the food effect on the pharmacokinetics, as well as PD and safety of AND017 following oral single-dose administration

Conditions

Interventions

TypeNameDescription
DRUGAND017AND017 oral capsule

Timeline

Start date
2020-07-30
Primary completion
2020-08-16
Completion
2020-08-21
First posted
2021-01-15
Last updated
2021-05-11

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04712500. Inclusion in this directory is not an endorsement.

A Food-Effect Study of AND017 in Healthy Participants (NCT04712500) · Clinical Trials Directory